Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1985-06-07
1988-06-21
Terapane, John F.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
128 11, A61K 4300, A61N 510
Patent
active
047524642
ABSTRACT:
Treatment of rheumatoid arthritis by administering a radioactive compound to the inflamed synovium of the articular joint. The compound comprises an aggregate suspension having a radionuclide entrapped therein. The aggregate suspension is a ferric or aluminum hydroxide aggregate, and the radionuclide is selected from the group consisting of .sup.166 Holmium, .sup.153 Samarium, .sup.175 Ytterbium, .sup.169 Erbium, and .sup.176m Lutetium. The radionculide may also consist of .sup.51 Chromium. Suitable leakage inhibitors or agents to reduce leakage of the radionuclide from the articular joint is included as part of the chemical composition of the final drug form.
REFERENCES:
patent: 3961038 (1976-06-01), Benes
Hackh's Chemical Dictionary, 4th Edition, McGraw-Hill, p. 168 (1969).
Singh et al, Indian J. Radiology, 25(4), Nov. 1971.
Hnatowich et al, CA 88:148276, 1978.
Rebut-Bonneton et al, CA 84:161223, 1976.
Bertrand et al, CA 87:1863, 1977.
Bard et al, CA 99:136168, 1983.
Bordoni Maurice E.
Lieberman Ephraim
Thornton Alfred K.
Bloom Leonard
Cadema Medical Products, Inc.
Terapane John F.
Thomas J. E.
LandOfFree
Treatment of arthritis, including rheumatoid arthritis, with rad does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of arthritis, including rheumatoid arthritis, with rad, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of arthritis, including rheumatoid arthritis, with rad will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-928862